Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowHematopoietic Stem Cell TransplantationWhole-Body IrradiationTransplantation ConditioningLeukemiaTransplantation, AutologousBone Marrow CellsTissue DonorsBusulfanAnemia, AplasticGraft SurvivalGraft vs Tumor EffectTransplantation ChimeraHistocompatibility TestingRecurrenceLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic NeoplasmsLeukocyte TransfusionLeukemia, Myeloid, AcuteRemission InductionHistocompatibilityRadiation ChimeraGraft vs Host ReactionPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft vs Leukemia EffectLymphocyte DepletionCyclophosphamideTreatment OutcomeImmunosuppressive AgentsTransplantation, IsogeneicCombined Modality TherapyAcute DiseaseTime FactorsGraft RejectionHepatic Veno-Occlusive DiseaseImmunosuppressionBone and BonesLymphocyte TransfusionLeukemia, MyeloidMice, Inbred C57BLT-LymphocytesSurvival AnalysisBone Marrow PurgingHematopoietic Stem CellsChimeraRetrospective StudiesTransplantation ImmunologyCyclosporineMyelodysplastic SyndromesKidney TransplantationNuclear FamilyHematopoiesisLiver TransplantationCytomegalovirus InfectionsHLA AntigensActuarial AnalysisSurvival RateDisease-Free SurvivalGranulocyte Colony-Stimulating FactorMice, Inbred BALB CHematologic DiseasesFatal OutcomeLymphoma, Non-HodgkinSevere Combined ImmunodeficiencyCytarabineFollow-Up StudiesBone Marrow DiseasesStem Cell TransplantationSpleenAntineoplastic Combined Chemotherapy ProtocolsHeart TransplantationIsoantigensPancytopeniaLeukocyte CountInfectionLymphocyte Culture Test, MixedAnemia, Refractory, with Excess of BlastsLeukemia, Myelomonocytic, AcuteImmunocompromised HostAntilymphocyte SerumLymphomaGanciclovirMethotrexateSkin TransplantationNeoplasm, ResidualFlow CytometryEtoposideMultiple MyelomaCyclosporinsLymphocyte ActivationBone Marrow ExaminationPrognosisMice, Inbred C3HLung TransplantationImmunophenotypingMinor Histocompatibility AntigensImmune Tolerance